Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001689375-23-000011

Chief Medical Officer sold 1,641 shares at an average $10.56 ($17,336)

  • Chief Medical Officer gave up 945 shares (to pay taxes)
  • Chief Medical Officer acquired 28,400 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
KREHER NERISSA Chief Medical Officer 2023-03-01 Grant or award +28,400 43,916 D: show line 1 in the form
KREHER NERISSA Chief Medical Officer 2023-03-02 Shares withheld for taxes −945 $11.60 $10,958 42,971 D: show line 2 in the form
KREHER NERISSA Chief Medical Officer 2023-03-02 Sale −1,477 $10.49 $15,496 41,494 D: show line 3 in the form
KREHER NERISSA Chief Medical Officer 2023-03-02 Sale −164 $11.22 $1,841 41,330 D: show line 4 in the form
Open-market sales · 1,641 sh · avg $10.56 · $17,336

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
KREHER NERISSA Chief Medical Officer 2023-03-01 Grant or award · Stock Option (Right to Buy) +43,000 43,000 D: show line 5 in the form
Loading xslF345X03/wf-form4_167787905815593.xml…